1. Home
  2. DBL vs NXPLW Comparison

DBL vs NXPLW Comparison

Compare DBL & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBL
  • NXPLW
  • Stock Information
  • Founded
  • DBL 2011
  • NXPLW N/A
  • Country
  • DBL United States
  • NXPLW United States
  • Employees
  • DBL N/A
  • NXPLW N/A
  • Industry
  • DBL
  • NXPLW Telecommunications Equipment
  • Sector
  • DBL
  • NXPLW Telecommunications
  • Exchange
  • DBL Nasdaq
  • NXPLW Nasdaq
  • Market Cap
  • DBL N/A
  • NXPLW N/A
  • IPO Year
  • DBL N/A
  • NXPLW N/A
  • Fundamental
  • Price
  • DBL $15.70
  • NXPLW $0.21
  • Analyst Decision
  • DBL
  • NXPLW
  • Analyst Count
  • DBL 0
  • NXPLW 0
  • Target Price
  • DBL N/A
  • NXPLW N/A
  • AVG Volume (30 Days)
  • DBL 61.0K
  • NXPLW 6.4K
  • Earning Date
  • DBL 01-01-0001
  • NXPLW 03-31-2025
  • Dividend Yield
  • DBL 8.67%
  • NXPLW N/A
  • EPS Growth
  • DBL N/A
  • NXPLW N/A
  • EPS
  • DBL N/A
  • NXPLW N/A
  • Revenue
  • DBL N/A
  • NXPLW $66,482,000.00
  • Revenue This Year
  • DBL N/A
  • NXPLW N/A
  • Revenue Next Year
  • DBL N/A
  • NXPLW N/A
  • P/E Ratio
  • DBL N/A
  • NXPLW N/A
  • Revenue Growth
  • DBL N/A
  • NXPLW 179.89
  • 52 Week Low
  • DBL $13.75
  • NXPLW $0.25
  • 52 Week High
  • DBL $15.70
  • NXPLW $0.26
  • Technical
  • Relative Strength Index (RSI)
  • DBL 50.19
  • NXPLW N/A
  • Support Level
  • DBL $15.69
  • NXPLW N/A
  • Resistance Level
  • DBL $15.91
  • NXPLW N/A
  • Average True Range (ATR)
  • DBL 0.11
  • NXPLW 0.00
  • MACD
  • DBL -0.02
  • NXPLW 0.00
  • Stochastic Oscillator
  • DBL 36.36
  • NXPLW 0.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: